Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study

Abstract

Pacemaker therapy is of clinical and haemodynamic benefit for patients with hypertrophic obstructive cardiomyopathy, left ventricular outflow gradient at rest over 30 mmHg who are symptomatic despite drug treatment.